Clinical Trial Update: Dinaciclib in Treating Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of dinaciclib in patients with Stage IV melanoma has results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acral Lentiginous Melanoma
• Cutaneous Melanoma
• Cutaneous Nodular Melanoma
• Lentigo Maligna Melanoma
• Melanoma
• Mucosal Melanoma

Drugs mentioned

• Dinaciclib (dinaciclib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acral Lentiginous Melanoma, Cutaneous Nodular Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2016-07-22